Serum N-terminal pro-B-type natriuretic peptide levels at the time of hospital admission predict of microvascular obstructions after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

Journal of Interventional Cardiology

Volumn 24, Issue 1, 2011, Pages 34-41

  Kim, Min Kyung ^a   Chung, Woo Young ^b,d   Cho, Young Seok ^c,d   Choi, Sang Il ^c   Chae, In Ho ^c,d   Choi, Dong Ju ^c,d   Park, Young Bae ^d  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB;

ADULT; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CONTRAST ECHOCARDIOGRAPHY; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; HEALTH STATUS INDICATORS; HOSPITALIZATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; STATISTICS AS TOPIC; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 79951622273     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00606.x     Document Type: Article

References (29)

1. Minamino N, Aburaya M, Ueda S, et al,. The presence of brain natriuretic peptide of 12,000 Daltons in porcine heart. Biochem Biophys Res Commun 1998; 155: 740-746.
2. Levin ER, Gardner DG, Samson WK,. Natriuretic peptides. N Engl J Med 1998; 339: 321-328. (Pubitemid 28366422)
3. Richards AM, Nicholls MG, Yandle TG, et al,. Plasma N-Terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921-1929.
4. Kwon TG, Bae JH, Jeong MH, et al,. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Med Image Anal 2009; 133 (2): 173-178.
5. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al,. The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am J Cardiol 2005; 95: 948-954. (Pubitemid 40487743)
6. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, et al,. Diagnostic and prognostic performance of N-terminal proBNP in primary care patients with suspected heart failure. J Card Fail 2005; 11: 15-20.
7. de Lemos JA, Morrow DA, Bentley JH, et al,. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
8. Kragelund C, Gronning B, Kober L, et al,. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352: 666-675. (Pubitemid 40239214)
9. Wang TJ, Larson MG, Levy D, et al,. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-663. (Pubitemid 38364624)
10. Cochet A, Zeller M, Cottin Y, et al,. The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction. Eur J Heart Fail 2004; 6: 555-560. (Pubitemid 39070508)
11. Bolognese L, Carrabba N, Parodi G, et al,. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation. 2004; 109: 1121-1126. (Pubitemid 38332616)
12. Taylor AJ, Al-Saadi N, Abdel-Sty H, et al,. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 2004; 109: 2080-2085. (Pubitemid 38620215)
13. Ragosta M, Camarano G, Kaul S, et al,. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: New insights using myocardial contrast echocardiography. Circulation 1994; 89: 2562-2569.
14. Maes A, Van de Werf F, Nuyts J, et al,. Impaired myocardial tissue perfusion early after successful thrombolysis: Impact on myocardial flow, metabolism, and function at late follow-up. Circulation 1995; 92: 2072-2078.
15. Hirsch A, Nijveldt R, Haeck JD, et al,. Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. J Am Coll Cardiol 2008; 51: 2230-2238. (Pubitemid 351754995)
16. Hong SN, Ahn Y, Hwang SH, et al,. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction. Am J Cardiol 2007; 100: 631-634. (Pubitemid 47223139)
17. Judd RM, Lugo-Olivieri CH, Arai M, et al,. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 1995; 92: 1902-1910.
18. Kim RJ, Chen E, Lima JAC, et al,. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996; 94: 3318-3326. (Pubitemid 26427504)
19. Gibson CM, Cannon CP, Murphy SA, et al,. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101 (2): 125-130. (Pubitemid 30044249)
20. Staat P, Rioufol G, Piot C, et al,. Postconditioning the human heart. Circulation 2005; 112: 2143-2148. (Pubitemid 41475808)
21. Zhao ZQ, Vinten-Johansen J,. Postconditioning: Reduction of reperfusion-induced injury. Cardiovasc Res 2006; 70: 200-211.
22. Zhao ZQ, Corvera JS, Halkos ME, et al,. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-H588. (Pubitemid 36885888)
23. Reffelmann T, Kloner RA,. The "no-reflow" phenomenon: Basic science and clinical correlates. Heart 2002; 87: 162-168. (Pubitemid 34098385)
24. Svilaas T, Vlaar PJ, Van Der Horst IC, et al,. Thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction. N Engl J Med 2008; 358: 557-567. (Pubitemid 351214283)
25. Heitzer T, Ollmann I, Koke K, et al,. Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease. Circulation 2003; 108: 536-541. (Pubitemid 36961166)
26. Yang YJ, Zhao JL, You SJ, et al,. Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion. Heart 2006; 92: 1131-1137.
27. Uyarel H, Uzunlar B, Unal Dayi S, et al,. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty. Cardiology 2006; 105: 168-175.
28. Genda S, Miura T, Miki T, et al,. K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia. J Am Coll Cardiol 2002; 40: 339-346.
29. Grube E, Gerckens U, Yeung AC, et al,. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 2001; 104: 2436-2441. (Pubitemid 33108377)